1-20 of 28
David Ritchie, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Ibrutinib in Combination with Venetoclax in Patients with Marginal Zone Lymphoma: Preliminary Results from an Open Label, Phase II Study

Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, Amit Khot, MBBS, MD MRCP, FRCPath, FRACP, Mary Ann Anderson, MBBS, PhD FRACP, FRCPA, Piers Blombery, MBBS, Kate Burbury, MBBS, FRACP, FRCPA, DPhil, David Ritchie, MD PhD, Rodney J. Hicks, MB BS (Hons), MD FRACP, FAHMS, Besiat Birbirsa, B.N., Mathias Bressel, M.Sc, Juliana Di Iulio, PhD, David Alan Westerman, MBBS, FRCPA, FRACP, Stephen Lade, MBBS, FRCPA, Andrew W. Roberts, MBBS, PhD, John F. Seymour, MBBS, PhD FRACP, Constantine S. Tam, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3999.
https://doi.org/10.1182/blood-2019-126396
Published: 2019
Journal Articles

Impact of Post-Transplant Consolidative Radiotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma and a PET-CT Based Predictive Model for Relapse

Collin Chin, MBBS, Andrew Wirth, MBBS, MD FRACP, FRANZCR, David Ritchie, MD PhD, Michael Hofman, MBBS (Hons), FRACP, FAANMS, Michael MacManus, John F. Seymour, MBBS, PhD FRACP, Belinda Campbell, MBBS, MMed, FRANZCR, Michael Dickinson, MBBS,FRACP,FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 4044.
https://doi.org/10.1182/blood-2019-122716
Published: 2019
Journal Articles

Long Term Responses to Venetoclax and Ibrutinib in Mantle Cell Lymphoma Are Associated with Immunological Recovery and Prognostic Changes in Inflammatory Biomarkers

Joanne Davis, PhD, Sasanka M Handunnetti, MBBS, Chia Sharpe, Gillian Turner, Mary Ann Anderson, MBBS, PhD FRACP, FRCPA, Andrew W. Roberts, MBBS, PhD, John F. Seymour, MBBS, PhD FRACP, Constantine S. Tam, MBBS, MD, David Ritchie, MD PhD, Rachel Koldej
Journal: Blood
Blood (2019) 134 (Supplement_1): 2791.
https://doi.org/10.1182/blood-2019-122974
Published: 2019
Journal Articles

Recipient Age and Marked Thrombocytopenia Are Associated with Increased Mortality in Patients with Poor Graft Function Post Allogeneic Transplantation

Ashvind Prabahran, MBBS, David Ritchie, MD PhD, Lynette C.Y. Chee, Rachel Koldej
Journal: Blood
Blood (2019) 134 (Supplement_1): 4512.
https://doi.org/10.1182/blood-2019-132046
Published: 2019
Journal Articles

Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE ® (Bispecific T-Cell Engager) in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Marion Subklewe, MD, Anthony Stein, MD, Roland B. Walter, MD PhD MS, Ravi Bhatia, MD, Andrew H. Wei, PhD FRACP, FRCPA, MBBS, David Ritchie, MD PhD, Veit Bücklein, MD, Pankit Vachhani, MD, Tian Dai, PhD, Antreas Hindoyan, PhD, Suresh Agarwal, PhD, Abraham Anderson, Sophia Khaldoyanidi, MD PhD, Farhad Ravandi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 833.
https://doi.org/10.1182/blood-2019-127977
Published: 2019
Journal Articles

Three Year Update of the Phase II ABT-199 (Venetoclax) and Ibrutinib in Mantle Cell Lymphoma (AIM) Study

Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, Mary Ann Anderson, MBBS, PhD FRACP, FRCPA, Kate Burbury, MBBS, FRACP, FRCPA, DPhil, Rodney J. Hicks, MB BS (Hons), MD FRACP, FAHMS, Besiat Birbirsa, B.N., Mathias Bressel, M.Sc, Juliana Di Iulio, PhD, David Alan Westerman, MBBS, FRCPA, FRACP, Stephen Lade, MBBS, FRCPA, Rishu Agarwal, Mark A. Dawson, PhD MBBS, Sarah-Jane Dawson, MD PhD, Rachel Koldej, David Ritchie, MD PhD, John F. Seymour, MBBS, PhD FRACP, Andrew W. Roberts, MBBS, PhD, Constantine S. Tam, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 756.
https://doi.org/10.1182/blood-2019-126619
Published: 2019
Journal Articles

Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1 st FLOR' Study

Allison Barraclough, Geoff Chong, Michael Gilbertson, Andrew Grigg, Leonid Churilov, Tineke Fancourt, David Ritchie, MD PhD, Rachel Koldej, Rishu Agarwal, Kate Manos, Charmaine Smith, Kristen Houdyk, Joanne Hawking, Eliza Hawkes
Journal: Blood
Blood (2019) 134 (Supplement_1): 1523.
https://doi.org/10.1182/blood-2019-123908
Published: 2019
Journal Articles

Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The RaDD Study

Eliza A Hawkes, Kate Manos, Geoff Chong, Jodie Palmer, Michael MacManus, Colm Keane, MD, Andrew Scott, Jake Shortt, MBBS FRACP FRCPA PhD, David Ritchie, MD PhD, Leonid Churilov, Laura Johnston, Tom Witkowski, Allison Barraclough, Sze-Ting Lee, Wendi Lin, Rachel Koldej, Richard Khor
Journal: Blood
Blood (2019) 134 (Supplement_1): 5328.
https://doi.org/10.1182/blood-2019-122635
Published: 2019
Journal Articles

Impact of Pre-Engraftment Cytomegalovirus Viraemia in Allogeneic Haematopoetic Stem Cell Transplant Recipients

Joanne L C Tan, MBBS, Shio Yen Tio, MBBS, FRACP, Michelle K Yong, MBBS, FRACP, MPH, PhD, David Ritchie, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5656.
https://doi.org/10.1182/blood-2019-122368
Published: 2019
Journal Articles

Mucositis during Allogeneic Transplantation Determines Post-Transplant Serum Cyclosporin Levels

Joanne L C Tan, MBBS, Eric Wong, MD, Ashish Bajel, MBBS, FRACP, FRCPA, Radha Ramanan, MBBS, Andrew B M Lim, David Ritchie, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5662.
https://doi.org/10.1182/blood-2019-122363
Published: 2019
Journal Articles

An Update of Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era

Yadanar Lwin, MBBS, MMed(InfnImm), FRACP, FRCPA, Simon Zhao-Xiong He, MBBS,FRACP,FRCPA, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Duncan Purtill, MBBS,FRCPA,FRACP, Ashley Mcewan, MBBS, Peter Browett, BMedSci, MBChB, FRACP, FRCPA, Andrew Butler, MB ChB(Edin), MRCP, MRCPath, John Carter, BMedSc MBChB FRACP FRCPA, Peter G Bardy, MBBS, FRACP, FRCPA, FRCPath, Glen A Kennedy, MBBS FRACP FRCPA, Jeffrey Szer, MBBS, David Ritchie, MD PhD, Matthew Greenwood, MBBS, FRACP, FRCPA, Stephen R Larsen, MBBS, PhD FRACP, FRCPA, Sam Milliken, MBBS, FRACP, FRCPA, Hock Choong Lai, MBBS, FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA, John Kwan, MBBS,FRACP,FRCPA, Donna Aarons, Steven Tran, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5719.
https://doi.org/10.1182/blood-2019-126547
Published: 2019
Journal Articles

Clinical Determinants of T-Cell Receptor Diversity after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

David Ritchie, MD PhD, Eric Wong, MD, Rachel Koldej, James Anton Kuzich, Piers Blombery, MBBS, Georgina L Ryland, Yamuna Kankanige, Jerick Guinto
Journal: Blood
Blood (2019) 134 (Supplement_1): 1997.
https://doi.org/10.1182/blood-2019-129308
Published: 2019
Journal Articles

The Economic and Health Utilization Cost of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Michelle K Yong, MBBS, FRACP, MPH, PhD, Shio Yen Tio, MBBS, FRACP, Jake Valentine, BBioMedSc, Joe Sasadeusz, MBBS FRACP PhD, Lynette C.Y. Chee, Ashish Bajel, MBBS, FRACP, FRCPA, David Ritchie, MD PhD, Monica Slavin, MBBS FRACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 3437.
https://doi.org/10.1182/blood-2019-128227
Published: 2019
Journal Articles

Administration of Third-Party Virus-Specific T-Cells (VST) at the Time of Initial Therapy for Infection after Haemopoietic Stem Cell Transplant Is Safe and Associated with Favourable Clinical Outcomes (the R3ACT-Quickly trial)

David Gottlieb, MBBS, MD FRACP, FRCPA, Wei Jiang, MBBS, BSc, BA, Selmir Avdic, PhD, Leighton Clancy, BSc PhD, Gaurav Sutrave, MBBS, Caroline M Bateman, PhDMBBS,FRACP,FRCPath,MRCP, Elissa Atkins, RN, Adrian Gabriel Selim, MBBS, Vicki Antonenas, BSc, David Collins, RN BSc (HONS) MN MapptMgt, Janine Street, BSc MSc (Hons), Renee Simms, BSc, Peter J. Shaw, MA,FRACP, David Ritchie, MD PhD, Emily Blyth, B. MDHons), FRACP, FRCPA, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 251.
https://doi.org/10.1182/blood-2019-125166
Published: 2019
Journal Articles

Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation

Glen A Kennedy, MBBS FRACP FRCPA, Siok-Keen Tey, MBBS,PhDFRACP,FRCPA, Cameron Curley, MBBS, FRACP, FRCPA, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Ashish Misra, MBBS, FRACP, Elango Subramoniapillai, MBBS, FRACP, James Morton, MBBS, FRACP, FRCPA, Simon Durrant, FRCP,FRCPath,MBBS, Andrea S Hendon, MBBS, PhD FRACP, FRCPA, John Moore, MDFRACP,FRCPA, David Ritchie, MD PhD, David Gottlieb, MBBS, MD FRACP, FRCPA, Julian Cooney, FRACP,FRCPA,MBBS,, Luke Buizen, BSc (Hons), MSc, Sanjoy K Paul, PhD, Geoff R. Hill, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 368.
https://doi.org/10.1182/blood-2019-126285
Published: 2019
Journal Articles

Hospital in the Home Delivery of Conditioning Therapy for Allogeneic Haematopoietic Stem Cell Transplantation: A Novel Single Centre Patient Focused Approach

David J M Routledge, MSc, PGCert, MRCP, FRCPath, Salvatore Fiorenza, MBBS,PhDMPH,BSc, Michael Montalto, Melissa Todd, Andrew B M Lim, David Ritchie, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1936.
https://doi.org/10.1182/blood.V130.Suppl_1.1936.1936
Published: 2017
Journal Articles

Natural Killer Receptor Ligand Expression By AML Blasts Determines Survival and Relapse Following Induction Chemotherapy

Sara Mastaglio, MD, Eric Wong, MD, Travis Perera, Ripley Jane, Piers Blombery, MBBS, Rachel Koldej, David Ritchie, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3948.
https://doi.org/10.1182/blood.V130.Suppl_1.3948.3948
Published: 2017
Journal Articles

Comparison of Outcomes of Elderly Patients with Acute Myeloid Leukemia (AML) in CR1 Receiving Reduced Intensity Allogeneic Stem Cell Transplantation (RICT) from Matched Sibling (MSD) or Unrelated Donors (URD)

Thomas L Kiss, MD, Elisabeth Wallhult, RN, Harald Anderson, PhD, Robert Delage, MD, Jürgen Finke, MD, Tobias Gedde-Dahl, MD PhD, Vladimir Lj Lazarevic, MD PhD, Kari Remes, MD PhD, David Ritchie, MD PhD, Mitchell Sabloff, MD, Alexandros Spyridonidis, MD PhD, Per Ljungman, Mats Brune, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4557.
https://doi.org/10.1182/blood.V130.Suppl_1.4557.4557
Published: 2017
Journal Articles

An International Multicenter Retrospective Comparison of Induction Chemoimmunotherapy Regimens on Outcomes in Patients with Transplant-Eligible Mantle Cell Lymphoma

Zi Yun Ng, MBBS, Mark Bishton, David Ritchie, MD PhD, Robert Campbell, Michael P Gilbertson, MBBS,FRACP,FRCPA, Kate Hill, Sumita Ratnasingam, MDFRACP,FRCPA, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Kate Manos, MBBS, Sophie Shorten, Melissa Liet Hing Ng, Niles Elizabeth Nelson, BSc, MBBS, Liu Xin, Sanjay De Mel, BSc,FRCPath,MRCP,, Tenny Sunny, Duncan Purtill, MBBS,FRCPA,FRACP, Michelle Poon, Anna M. Johnston, FRACP, FRCPA, MBBS, Tara Cochrane, MBBS, Hui-Peng Lee, MD, Greg Hapgood, BMBS, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Stephen Opat, FRACP, FRCPA, Eliza A Hawkes, FRACP, MBBS, John F Seymour, MBBS, PhD, Chan Yoon Cheah, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4052.
https://doi.org/10.1182/blood.V130.Suppl_1.4052.4052
Published: 2017
Journal Articles

Baseline Biomarkers Influencing Clinical Outcomes in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) Treated with Blinatumomab Versus Standard-of-Care Chemotherapy (SOC) from a Randomized Phase 3 Study

Andrew Wei, MBBS, PhD FRACP, FRCPA, Josep-Maria Ribera, MD, Giovanni Martinelli, Richard A. Larson, MD, David Ritchie, MD PhD, Armin Ghobadi, MD, Yuqi Chen, Cedric E. Dos Santos, Zachary F. Zimmerman, MD PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2556.
https://doi.org/10.1182/blood.V130.Suppl_1.2556.2556
Published: 2017